Evidence map›Paper›PMID 31441057›Full record

ArticlePhotochemistry and photobiology2020

Predictors and Limitations of the Penetration Depth of Photodynamic Effects in the Rodent Brain.

Collin T Inglut, Brandon Gaitan, Daniel Najafali, Irati Abad Lopez, Nina P Connolly, Seppo Orsila, Robert Perttilä, Graeme F Woodworth, Yu Chen, Huang-Chiao Huang

Open access · greenAbstract read
In one paragraph

Article in Photochemistry and photobiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Application of Photodynamic Therapy in Cardiology.International journal of molecular sciences · 2024
    Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Collin T Inglut *Fischell Department of Bioengineering, University of Maryland, College Park, MD.
Brandon Gaitan *Fischell Department of Bioengineering, University of Maryland, College Park, MD.
Daniel NajafaliFischell Department of Bioengineering, University of Maryland, College Park, MD.ORCID 0000-0003-1509-9229
Irati Abad LopezFischell Department of Bioengineering, University of Maryland, College Park, MD.
Nina P ConnollyMarlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD.
Seppo OrsilaModulight, Inc., Tampere, Finland.
Robert PerttiläModulight, Inc., Tampere, Finland.ORCID 0000-0001-8030-7077
Graeme F WoodworthMarlene and Stewart Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD.
Yu ChenFischell Department of Bioengineering, University of Maryland, College Park, MD.
Huang-Chiao HuangFischell Department of Bioengineering, University of Maryland, College Park, MD.ORCID 0000-0002-5406-0733
University of Maryland, Baltimore · USUniversity of Maryland, College Park · USModulight (Finland) · FI

Funding

Multifunctional, GBM-Activatable Nanocarriers For Image-Guided PhotochemotherapyR00CA194269 · NCI · UNIV OF MARYLAND, COLLEGE PARK · PI HUANG, HUANG CHIAO · 2018 to 2020
$701k
NCI NIH HHS R00 CA194269
6 · The paper itself

Abstract

Fluorescence-guided surgery (FGS) is routinely utilized in clinical centers around the world, whereas the combination of FGS and photodynamic therapy (PDT) has yet to reach clinical implementation and remains an active area of translational investigations. Two significant challenges to the clinical translation of PDT for brain cancer are as follows: (1) Limited light penetration depth in brain tissues and (2) Poor selectivity and delivery of the appropriate photosensitizers. To address these shortcomings, we developed nanoliposomal protoporphyrin IX (Nal-PpIX) and nanoliposomal benzoporphyrin derivative (Nal-BPD) and then evaluated their photodynamic effects as a function of depth in tissue and light fluence using rat brains. Although red light penetration depth (defined as the depth at which the incident optical energy drops to 1/e, ~37%) is typically a few millimeters in tissues, we demonstrated that the remaining optical energy could induce PDT effects up to 2 cm within brain tissues. Photobleaching and singlet oxygen yield studies between Nal-BPD and Nal-PpIX suggest that deep-tissue PDT (>1 cm) is more effective when using Nal-BPD. These findings indicate that Nal-BPD-PDT is more likely to generate cytotoxic effects deep within the brain and allow for the treatment of brain invading tumor cells centimeters away from the main, resectable tumor mass.

Indexed as

PhotochemotherapyAnimalsBrain NeoplasmsPhotosensitizing AgentsRatsSpectrometry, FluorescencePhotosensitizing Agents

Identifiers

PMID31441057
PMCPMC7035972
OpenAlexW2969260234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.